The U.S. House of Representatives on Wednesday approved a bipartisan pair of psychedelic research amendments, along with another measure requiring a military study of marijuana-related discrimination in the armed forces.
The day after the release of nine drug policy amendments to the National Defense Authorization Act (NDAA) done in order for the ground review by the House Rules Committee, the chamber voted in favor of an initial set of consolidated measures, including those that contain language requiring research into the therapeutic potential of substances like psilocybin, MDMA and ibogaine in addition to proposal on cannabis. Approval came on a voice vote.
Debating in the House and voting on the remaining marijuana amendments cleared for floor action will be a multi-day process, but the three that have cleared the House so far as part of a bloc group are particularly unique.
Rep. Dan Crenshaw’s (R-TX) amendment would allow the Secretary of Defense to approve grants for research into the therapeutic potential of certain psychedelics such as MDMA, psilocybin, ibogaine and 5-MeO- DMT for active duty military personnel with PTSD.
In particular, an identical earlier version of the was not made for the floor as part of last year’s NDAA, noting that attitudes towards
Read the full article at Marijuana Time
#House #Approves #Marijuana #Psychedelics #Amendments #Part #MustPass #Defense #Bill